The International Cricket Council (ICC) on Tuesday announced that South African batter Zubayr Hamza has been suspended from all cricket-related activities for nine months after admitting to an anti-doping rule violation under the ICC Anti-Doping Code.
Hamza provided an out-of-competition sample on January 17 2022 in Paarl, South Africa, in which the prohibited substance Furosemide - a substance on 2022 WADA Prohibited List - was found.
He admitted the violation and, having established no significant fault or negligence on his part, a nine-month period of ineligibility has been imposed, backdated to 22 March 2022, the date that Hamza accepted a provisional suspension. The effect of this suspension is that Hamza will be eligible to return to cricket on 22 December 2022.
In addition, all of Hamza’s individual performances between January 17 and March 17, 2022 have been disqualified. The decision by ICC means Hamza's innings of 6 and 25 in the second Test against New Zealand in February this year will be chalked out from his Test runs tally of 212.
Alex Marshall, ICC General Manager – Integrity Unit said that the players are solely responsible to make sure their medication doesn't contain any banned substances. “The ICC is committed to keeping cricket clean and has a zero-tolerance approach to doping. It is also a timely reminder to all international cricketers that they remain responsible for anything they put into their bodies, to know exactly what medication they are taking so as to ensure it does not contain a prohibited substance and does not result in an anti-doping rule violation.”